Recombinant Human TIMP-1, CF

Name	Recombinant Human TIMP-1, CF
Supplier	R&D Systems
Catalog	970-TM-010
Category	Protein
Nature	Recombinant
Source	Mouse myeloma cell line, NS0-derived, Cys24-Ala207
Purity	>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
SwissProt/Accession	Q6FGX5
Gene	TIMP1
Supplier Page	Shop

Product References

Tissue inhibitor of matrix metalloproteinase 1 (TIMP1) controls adipogenesis in - Tissue inhibitor of matrix metalloproteinase 1 (TIMP1) controls adipogenesis in

Meissburger B, Stachorski L, Roder E, Rudofsky G, Wolfrum C. Diabetologia. 2011 Jun;54(6):1468-79.

A multiplex immunoassay for human adipokine profiling. - A multiplex immunoassay for human adipokine profiling.

Schipper HS, de Jager W, van Dijk ME, Meerding J, Zelissen PM, Adan RA, Prakken BJ, Kalkhoven E. Clin Chem. 2010 Aug;56(8):1320-8.

Decorin is a novel antagonistic ligand of the Met receptor. - Decorin is a novel antagonistic ligand of the Met receptor.

Goldoni S, Humphries A, Nystrom A, Sattar S, Owens RT, McQuillan DJ, Ireton K, Iozzo RV. J Cell Biol. 2009 May 18;185(4):743-54.

Use of an immunoaffinity-mass spectrometry-based approach for the quantification - Use of an immunoaffinity-mass spectrometry-based approach for the quantification

Nicol GR, Han M, Kim J, Birse CE, Brand E, Nguyen A, Mesri M, FitzHugh W, Kaminker P, Moore PA, Ruben SM, He T. Mol Cell Proteomics. 2008 Oct;7(10):1974-82.

Monocytes/macrophages cooperate with progenitor cells during neovascularization - Monocytes/macrophages cooperate with progenitor cells during neovascularization

Anghelina M, Krishnan P, Moldovan L, Moldovan NI. Am J Pathol. 2006 Feb;168(2):529-41.

GPI-anchored TIMP-1 treatment renders renal cell carcinoma sensitive to - GPI-anchored TIMP-1 treatment renders renal cell carcinoma sensitive to

Djafarzadeh R, Noessner E, Engelmann H, Schendel DJ, Notohamiprodjo M, von Luettichau I, Nelson PJ. Oncogene. 2006 Mar 9;25(10):1496-508.

Depletion of cellular cholesterol and lipid rafts increases shedding of CD30. - Depletion of cellular cholesterol and lipid rafts increases shedding of CD30.

von Tresckow B, Kallen KJ, von Strandmann EP, Borchmann P, Lange H, Engert A, Hansen HP. J Immunol. 2004 Apr 1;172(7):4324-31.